Glaxo
- All
- News
- Videos
-
All 37 Omicron Mutations Defeated By This New Antibody Treatment
GlaxoSmithKline Plc said research shows its Covid-19 antibody treatment is effective against the full combination of mutations in the new omicron variant.
-
Glaxo Head Optimistic COVID-19 Vaccine Widely Available In 2021
The chief executive of GlaxoSmithKline, the world's largest maker of vaccines, said she was optimistic the industry will be able to make an immunisation against COVID-19 widely available next year.
-
Pentagon Awards Glaxo $342 Million Contract For COVID Vaccines
The Pentagon on Thursday announced a $342 million contract has been awarded to British pharmaceutical giant GlaxoSmithKline to deliver "mass quantities of COVID-19 vaccines" to US troops.
-
Government's Plan To Pull In 324 Companies Including Tesla, Glaxo: Report
The government is planning to offer 324 companies including Tesla Inc. and GlaxoSmithKline Plc incentives to set up factories in India in a bid to capitalize from the trade war between China and the US., according to a document seen by Bloomberg.
-
AI Test Pinpoints More Cancers Targeted by Astra, Glaxo Drugs
Oncology is among the fastest-growing fields in the pharmaceutical industry, with an armada of newly developed treatments sending annual sales surging to about $133 billion.
-
Ebola Vaccine from Glaxo Passes Early Safety Test
An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine.
-
Supreme Court asks Centre to investigate 'unauthorised' clinical trials
The Supreme Court today issued notice to the Centre on a Public Interest Litigation (PIL), which alleges that pharma company Glaxo Smithkline had conducted unauthorised trials of its vaccine on tribal girls.
-
Glaxo to pay $750 million for sale of bad products
GlaxoSmithKline, the British drug giant, has agreed to pay $750 million to settle criminal and civil complaints that the company for years knowingly sold contaminated baby ointment and an ineffective antidepressant -- the latest in a growing number of whistle-blower lawsuits that drug makers have settled with multimillion-dollar fines.Altogether, G...
-
A cheap anti-malarial being developed
GlaxoSmithKline are on the verge of developing a cheap anti-malarial drug, LAPDAP, in collaboration with the World Health Organisation (WHO), for use in the under-developed countries. Malaria is an infectious disease caused by the female anopheles mosquito, and is still rampant in Africa and India. Though it is eminently treatable, the medicines m...
-
All 37 Omicron Mutations Defeated By This New Antibody Treatment
GlaxoSmithKline Plc said research shows its Covid-19 antibody treatment is effective against the full combination of mutations in the new omicron variant.
-
Glaxo Head Optimistic COVID-19 Vaccine Widely Available In 2021
The chief executive of GlaxoSmithKline, the world's largest maker of vaccines, said she was optimistic the industry will be able to make an immunisation against COVID-19 widely available next year.
-
Pentagon Awards Glaxo $342 Million Contract For COVID Vaccines
The Pentagon on Thursday announced a $342 million contract has been awarded to British pharmaceutical giant GlaxoSmithKline to deliver "mass quantities of COVID-19 vaccines" to US troops.
-
Government's Plan To Pull In 324 Companies Including Tesla, Glaxo: Report
The government is planning to offer 324 companies including Tesla Inc. and GlaxoSmithKline Plc incentives to set up factories in India in a bid to capitalize from the trade war between China and the US., according to a document seen by Bloomberg.
-
AI Test Pinpoints More Cancers Targeted by Astra, Glaxo Drugs
Oncology is among the fastest-growing fields in the pharmaceutical industry, with an armada of newly developed treatments sending annual sales surging to about $133 billion.
-
Ebola Vaccine from Glaxo Passes Early Safety Test
An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine.
-
Supreme Court asks Centre to investigate 'unauthorised' clinical trials
The Supreme Court today issued notice to the Centre on a Public Interest Litigation (PIL), which alleges that pharma company Glaxo Smithkline had conducted unauthorised trials of its vaccine on tribal girls.
-
Glaxo to pay $750 million for sale of bad products
GlaxoSmithKline, the British drug giant, has agreed to pay $750 million to settle criminal and civil complaints that the company for years knowingly sold contaminated baby ointment and an ineffective antidepressant -- the latest in a growing number of whistle-blower lawsuits that drug makers have settled with multimillion-dollar fines.Altogether, G...
-
A cheap anti-malarial being developed
GlaxoSmithKline are on the verge of developing a cheap anti-malarial drug, LAPDAP, in collaboration with the World Health Organisation (WHO), for use in the under-developed countries. Malaria is an infectious disease caused by the female anopheles mosquito, and is still rampant in Africa and India. Though it is eminently treatable, the medicines m...
